Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!
- PMID: 20975018
- DOI: 10.1001/archinternmed.2010.382
Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!
Abstract
Background: Red yeast rice (RYR) is a widely available dietary supplement used by millions of patients as an alternative therapy for hyperlipidemia. It contains 14 active compounds called monacolins that inhibit hepatic cholesterol synthesis. Although studies have suggested that some formulations of RYR may be effective and safe for lipid lowering, monacolin levels are not standardized among marketed products and are generally not published on labels. We evaluated monacolin levels in 12 commercial RYR formulations and tested for citrinin, a mycotoxin that is nephrotoxic in animals.
Methods: Each formulation of RYR was labeled "600 mg/capsule" of active product. Analyses for monacolins and citrinin were performed between August 2006 and June 2008 using high-performance liquid chromatography with mass spectroscopy-mass spectroscopy detection. Laboratory analyses of RYR products were conducted by ConsumerLab.com, White Plains, New York.
Results: There was marked variability in the 12 RYR products in total monacolins (0.31-11.15 mg/capsule), monacolin K (lovastatin) (0.10-10.09 mg/capsule), and monacolin KA (0.00-2.30 mg/capsule). Four products had elevated levels of citrinin.
Conclusions: We found striking variability in monacolin content in 12 proprietary RYR products and the presence of citrinin in one-third of the formulations tested. Although RYR may have potential as an alternative lipid-lowering agent, our findings suggest the need for improved standardization of RYR products and product labeling. Until this occurs, physicians should be cautious in recommending RYR to their patients for the treatment of hyperlipidemia and primary and secondary prevention of cardiovascular disease.
Comment in
-
Monacolin levels in red yeast rice: methodological questions.Arch Intern Med. 2011 May 23;171(10):950-1; author reply 951. doi: 10.1001/archinternmed.2011.193. Arch Intern Med. 2011. PMID: 21606105 No abstract available.
Similar articles
-
The Impact of Red Yeast Rice Extract Use on the Occurrence of Muscle Symptoms and Liver Dysfunction: An Update from the Adverse Event Reporting Systems and Available Meta-Analyses.Nutrients. 2024 Feb 2;16(3):444. doi: 10.3390/nu16030444. Nutrients. 2024. PMID: 38337728 Free PMC article. Review.
-
Chemical profiling and quantification of monacolins and citrinin in red yeast rice commercial raw materials and dietary supplements using liquid chromatography-accurate QToF mass spectrometry: Chemometrics application.J Pharm Biomed Anal. 2014 Nov;100:243-253. doi: 10.1016/j.jpba.2014.07.039. Epub 2014 Aug 9. J Pharm Biomed Anal. 2014. PMID: 25168220
-
Review of red yeast rice content and current Food and Drug Administration oversight.J Clin Lipidol. 2013 Mar-Apr;7(2):117-22. doi: 10.1016/j.jacl.2012.09.003. Epub 2012 Sep 25. J Clin Lipidol. 2013. PMID: 23415430 Review.
-
Development of a rapid LC/DAD/FLD/MS(n) method for the simultaneous determination of monacolins and citrinin in red fermented rice products.J Agric Food Chem. 2013 Feb 6;61(5):1072-80. doi: 10.1021/jf304881g. Epub 2013 Jan 24. J Agric Food Chem. 2013. PMID: 23305336
-
An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents.J Altern Complement Med. 2001 Apr;7(2):133-9. doi: 10.1089/107555301750164181. J Altern Complement Med. 2001. PMID: 11327519
Cited by
-
ITC study on the interaction of some bile salts with tragacanth, Arabic, and guar gums with potential cholesterol-lowering ability.Front Nutr. 2023 Oct 24;10:1258282. doi: 10.3389/fnut.2023.1258282. eCollection 2023. Front Nutr. 2023. PMID: 37941767 Free PMC article.
-
Alpha-Linolenic Acid and Cardiovascular Events: A Narrative Review.Int J Mol Sci. 2023 Sep 20;24(18):14319. doi: 10.3390/ijms241814319. Int J Mol Sci. 2023. PMID: 37762621 Free PMC article. Review.
-
Supplements for Lipid Lowering: What Does the Evidence Show?Curr Cardiol Rep. 2023 Aug;25(8):795-805. doi: 10.1007/s11886-023-01903-9. Epub 2023 Jun 10. Curr Cardiol Rep. 2023. PMID: 37300664 Review.
-
The Questionable Quality Profile of Food Supplements: The Case of Red Yeast Rice Marketed Products.Foods. 2023 May 25;12(11):2142. doi: 10.3390/foods12112142. Foods. 2023. PMID: 37297387 Free PMC article.
-
Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review.Nutrients. 2023 May 12;15(10):2288. doi: 10.3390/nu15102288. Nutrients. 2023. PMID: 37242171 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical